GlassScriptPhysician profile
Eric Yt Yang
NPI 1669420113
$31,774.78
in general payments reported to CMS, 2019-2025
28 companies · $13K in 2025
The $13K reported for 2025 was more than what 96% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,946 · 2020: $579 · 2021: $720 · 2022: $1,452 · 2023: $2,468 · 2024: $11K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Consulting Fee: $6,325 · Food and Beverage: $4,623 · Travel and Lodging: $2,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,025.00 |
| Consulting Fee | $6,325.00 |
| Food and Beverage | $4,623.12 |
| Travel and Lodging | $2,105.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $27,460.24 | 2019-2025 | Grafix, Na, Oasis |
| Organogenesis INC. | $1,279.95 | 2019-2024 | Puraply, Apligraf |
| Kerecis Limited | $664.60 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Mimedx Group, INC. | $420.45 | 2025 | |
| Kci USA, INC. | $318.20 | 2019-2023 | V.A.C. Dermatac, V.A.C. Veraflo Cleanse Choice |
| Urgo Medical North America, LLC | $299.90 | 2024-2025 | Urgoclean Ag, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Intuitive Surgical, INC. | $291.56 | 2019 | |
| Solventum Corporation | $186.41 | 2024-2025 | Prevena, V.A.C. Veraflo Cleanse Choice, Activ.A.C. |
| Tactile Systems Technology INC | $136.95 | 2019 | |
| Aroa Biosurgery Incorporated | $114.00 | 2019 | |
| Shire North American Group INC | $72.38 | 2019 | |
| Ets Wound Care LLC | $56.42 | 2025 | Mirragen Advanced Wound Matrix |
| Davol INC. | $50.02 | 2019 | |
| Bsn Medical INC | $45.63 | 2019 | |
| Angiodynamics, INC. | $41.52 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $39.88 | 2021 | |
| Baxter Healthcare | $37.69 | 2024 | Perclot |
| Takeda Pharmaceuticals U.S.A., INC. | $36.50 | 2020-2021 | |
| Polynovo North America LLC | $34.20 | 2024 | Novosorb Btm |
| Kowa Pharmaceuticals America, INC. | $28.54 | 2022 | |
| Lifenet Health | $26.69 | 2024 | Theragenesis Wound Matrix |
| Merck Sharp & Dohme LLC | $26.42 | 2019 | |
| Stryker Corporation | $21.33 | 2021 | |
| Melinta Therapeutics, LLC | $20.60 | 2019 | |
| Pfizer INC. | $18.31 | 2025 | |
| Paratek Pharmaceuticals, INC. | $17.33 | 2022 | |
| Medela LLC | $16.49 | 2022 | |
| Allergan, INC. | $12.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.